{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:24:26Z","timestamp":1793845466814,"version":"4.6.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1111\/j.1574-695x.2009.00580.x","type":"journal-article","created":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T15:53:48Z","timestamp":1246463628000},"page":"69-79","source":"Crossref","is-referenced-by-count":36,"title":["Use of stabilized luciferase-expressing plasmids to examine<i>in vivo<\/i>-induced promoters in the<i>Vibrio cholerae<\/i>vaccine strain CVD 103-HgR"],"prefix":"10.1093","volume":"57","author":[{"given":"Cara E.","family":"Morin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Kaper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB1","doi-asserted-by":"crossref","unstructured":"Altboum Z , Barry EM , Losonsky G , Galen JE & Levine MM (2001) Attenuated Shigella flexneri 2a \u00ce\u0094guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection. Infect Immun 69: 3150\u00e2\u0080\u00933158.","DOI":"10.1128\/IAI.69.5.3150-3158.2001"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB2","doi-asserted-by":"crossref","unstructured":"Altboum Z , Levine MM , Galen JE & Barry EM (2003) Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain. Infect Immun 71: 1352\u00e2\u0080\u00931360.","DOI":"10.1128\/IAI.71.3.1352-1360.2003"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB3","doi-asserted-by":"crossref","unstructured":"Bumann D (2001) Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses. Infect Immun 69: 7493\u00e2\u0080\u00937500.","DOI":"10.1128\/IAI.69.12.7493-7500.2001"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB5","doi-asserted-by":"crossref","unstructured":"Butterton JR , Ryan ET , Shahin RA & Calderwood SB (1996) Development of a germfree mouse model of Vibrio cholerae infection. Infect Immun 64: 4373\u00e2\u0080\u00934377.","DOI":"10.1128\/IAI.64.10.4373-4377.1996"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB4","doi-asserted-by":"crossref","unstructured":"Butterton JR , Ryan ET , Acheson DW & Calderwood SB (1997) Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect Immun 65: 2127\u00e2\u0080\u00932135.","DOI":"10.1128\/IAI.65.6.2127-2135.1997"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB59","first-page":"1458","volume-title":"Escherichia coli and Salmonella: Cellular and Molecular Biology","author":"Cashel","year":"1996"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB55","volume-title":"EcoSal-Escherichia coli and Salmonella: Cellular and Molecular Biology","author":"Charlier","year":"2004"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB8","doi-asserted-by":"crossref","unstructured":"Chen I , Finn TM , Yanqing L , Guoming Q , Rappuoli R & Pizza M (1998) A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. Infect Immun 66: 1648\u00e2\u0080\u00931653.","DOI":"10.1128\/IAI.66.4.1648-1653.1998"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB9","unstructured":"Chiang SL & Mekalanos JJ (1998) Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization. Mol Microbiol 27: 797\u00e2\u0080\u0093805."},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB10","doi-asserted-by":"crossref","unstructured":"Contag PR (2008) Bioluminescence imaging to evaluate infections and host response in vivo. Methods Mol Biol 415: 101\u00e2\u0080\u0093118.","DOI":"10.1007\/978-1-59745-570-1_6"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB12","unstructured":"Cryz SJ Jr , Levine MM , Kaper JB , Furer E & Althaus B (1990) Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults. Vaccine 8: 577\u00e2\u0080\u0093580."},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB13","unstructured":"Cryz SJ Jr , Levine MM , Losonsky G , Kaper JB & Althaus B (1992) Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults. Infect Immun 60: 3916\u00e2\u0080\u00933917."},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB11","unstructured":"Cryz SJ Jr , Kaper J , Tacket C , Nataro J & Levine MM (1995) Vibrio cholerae CVD 103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects. Dev Biol Stand 84: 237\u00e2\u0080\u0093244."},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB14","doi-asserted-by":"crossref","unstructured":"Cunin R , Glansdorff N , Pierard A & Stalon V (1986) Biosynthesis and metabolism of arginine in bacteria. Microbiol Rev 50: 314\u00e2\u0080\u0093352.","DOI":"10.1128\/MMBR.50.3.314-352.1986"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB15","doi-asserted-by":"crossref","unstructured":"Fang CM , Wang JY , Chinchilla M , Levine MM , Blackwelder WC & Galen JE (2008) Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors. Infect Immun 76: 4422\u00e2\u0080\u00934430.","DOI":"10.1128\/IAI.00487-08"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB16","doi-asserted-by":"crossref","unstructured":"Fontana MR , Monaci E , Yanqing L , Guoming Q , Duan G , Rappuoli R & Pizza M (2000) IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin. Vaccine 19: 75\u00e2\u0080\u009385.","DOI":"10.1016\/S0264-410X(00)00137-7"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB18","doi-asserted-by":"crossref","unstructured":"Galen JE & Levine MM (2001) Can a \u00e2\u0080\u0098flawless\u00e2\u0080\u0099 live vector vaccine strain be engineered? Trends Microbiol 9: 372\u00e2\u0080\u0093376.","DOI":"10.1016\/S0966-842X(01)02096-0"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB17","doi-asserted-by":"crossref","unstructured":"Galen JE , Gomez-Duarte OG , Losonsky GA , Halpern JL , Lauderbaugh CS , Kaintuck S , Reymann MK & Levine MM (1997) A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 15: 700\u00e2\u0080\u0093708.","DOI":"10.1016\/S0264-410X(96)00227-7"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB19","doi-asserted-by":"crossref","unstructured":"Galen JE , Nair J , Wang JY , Wasserman SS , Tanner MK , Sztein MB & Levine MM (1999) Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect Immun 67: 6424\u00e2\u0080\u00936433.","DOI":"10.1128\/IAI.67.12.6424-6433.1999"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB20","doi-asserted-by":"crossref","unstructured":"Galen JE , Zhao L , Chinchilla M , Wang JY , Pasetti MF , Green J & Levine MM (2004) Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA. Infect Immun 72: 7096\u00e2\u0080\u00937106.","DOI":"10.1128\/IAI.72.12.7096-7106.2004"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB21","unstructured":"Galluzzi L & Karp M (2007) Intracellular redox equilibrium and growth phase affect the performance of luciferase-based biosensors. J Biotechnol 127: 188\u00e2\u0080\u0093198."},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB22","doi-asserted-by":"crossref","unstructured":"Glick BR (1995) Metabolic load and heterologous gene expression. Biotechnol Adv 13: 247\u00e2\u0080\u0093261.","DOI":"10.1016\/0734-9750(95)00004-A"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB23","doi-asserted-by":"crossref","unstructured":"Hang L , John M , Asaduzzaman M et al. (2003) Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae. P Natl Acad Sci U S A 100: 8508\u00e2\u0080\u00938513.","DOI":"10.1073\/pnas.1431769100"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB24","doi-asserted-by":"crossref","unstructured":"Hardy J , Francis KP , DeBoer M , Chu P , Gibbs K & Contag CH (2004) Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science 303: 851\u00e2\u0080\u0093853.","DOI":"10.1126\/science.1092712"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB56","volume-title":"New Generation Vaccines","author":"Holmgren","year":"2009"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB25","doi-asserted-by":"crossref","unstructured":"Holmgren J , Adamsson J , Anjuere F et al. (2005) Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett 97: 181\u00e2\u0080\u0093188.","DOI":"10.1016\/j.imlet.2004.11.009"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB27","doi-asserted-by":"crossref","unstructured":"John M , Crean TI , Calderwood SB & Ryan ET (2000) In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae. Infect Immun 68: 1171\u00e2\u0080\u00931175.","DOI":"10.1128\/IAI.68.3.1171-1175.2000"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB28","doi-asserted-by":"crossref","unstructured":"Klose KE (2000) The suckling mouse model of cholera. Trends Microbiol 8: 189\u00e2\u0080\u0093191.","DOI":"10.1016\/S0966-842X(00)01721-2"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB29","doi-asserted-by":"crossref","unstructured":"Koga K , Harada T , Shimizu H & Tanaka K (2005) Bacterial luciferase activity and the intracellular redox pool in Escherichia coli. Mol Genet Genomics 274: 180\u00e2\u0080\u0093188.","DOI":"10.1007\/s00438-005-0008-5"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB30","doi-asserted-by":"crossref","unstructured":"Kotloff KL , Wasserman SS , O'Donnell S , Losonsky GA , Cryz SJ & Levine MM (1992) Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial. Infect Immun 60: 4430\u00e2\u0080\u00934432.","DOI":"10.1128\/IAI.60.10.4430-4432.1992"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB31","doi-asserted-by":"crossref","unstructured":"Lane MC , Alteri CJ , Smith SN & Mobley HL (2007) Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. P Natl Acad Sci USA 104: 16669\u00e2\u0080\u009316674.","DOI":"10.1073\/pnas.0607898104"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB32","doi-asserted-by":"crossref","unstructured":"Larocque RC , Harris JB , Dziejman M et al. (2005) Transcriptional profiling of Vibrio cholerae recovered directly from patient specimens during early and late stages of human infection. Infect Immun 73: 4488\u00e2\u0080\u00934493.","DOI":"10.1128\/IAI.73.8.4488-4493.2005"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB33","doi-asserted-by":"crossref","unstructured":"Larocque RC , Krastins B , Harris JB , Lebrun LM , Parker KC , Chase M , Ryan ET , Qadri F , Sarracino D & Calderwood SB (2008) Proteomic analysis of Vibrio cholerae in human stool. Infect Immun 76: 4145\u00e2\u0080\u00934151.","DOI":"10.1128\/IAI.00585-08"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB34","doi-asserted-by":"crossref","unstructured":"Lee SH , Butler SM & Camilli A (2001) Selection for in vivo regulators of bacterial virulence. P Natl Acad Sci USA 98: 6889\u00e2\u0080\u00936894.","DOI":"10.1073\/pnas.111581598"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB35","doi-asserted-by":"crossref","unstructured":"Liang W , Wang S , Yu F , Zhang L , Qi G , Liu Y , Gao S & Kan B (2003) Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108. Infect Immun 71: 5498\u00e2\u0080\u00935504.","DOI":"10.1128\/IAI.71.10.5498-5504.2003"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB36","doi-asserted-by":"crossref","unstructured":"Lombardo MJ , Michalski J , Martinez-Wilson H , Morin C , Hilton T , Osorio CG , Nataro JP , Tacket CO , Camilli A & Kaper JB (2007) An in vivo expression technology screen for Vibrio cholerae genes expressed in human volunteers. P Natl Acad Sci USA 104: 18229\u00e2\u0080\u009318234.","DOI":"10.1073\/pnas.0705636104"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB37","unstructured":"Londono LP , Chatfield S , Tindle RW , Herd K , Gao XM , Frazer I & Dougan G (1996) Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine 14: 545\u00e2\u0080\u0093552."},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB38","unstructured":"Marcus H , Ketley JM , Kaper JB & Holmes RK (1990) Effects of DNase production, plasmid size, and restriction barriers on transformation of Vibrio cholerae by electroporation and osmotic shock. FEMS Microbiol Lett 56: 149\u00e2\u0080\u0093154."},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB39","doi-asserted-by":"crossref","unstructured":"Merrell DS , Butler SM , Qadri F , Dolganov NA , Alam A , Cohen MB , Calderwood SB , Schoolnik GK & Camilli A (2002a) Host-induced epidemic spread of the cholera bacterium. Nature 417: 642\u00e2\u0080\u0093645.","DOI":"10.1038\/nature00778"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB40","doi-asserted-by":"crossref","unstructured":"Merrell DS , Hava DL & Camilli A (2002b) Identification of novel factors involved in colonization and acid tolerance of Vibrio cholerae. Mol Microbiol 43: 1471\u00e2\u0080\u00931491.","DOI":"10.1046\/j.1365-2958.2002.02857.x"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB41","doi-asserted-by":"crossref","unstructured":"Mey AR , Wyckoff EE , Kanukurthy V , Fisher CR & Payne SM (2005) Iron and fur regulation in Vibrio cholerae and the role of fur in virulence. Infect Immun 73: 8167\u00e2\u0080\u00938178.","DOI":"10.1128\/IAI.73.12.8167-8178.2005"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB42","doi-asserted-by":"crossref","unstructured":"Min JJ , Kim HJ , Park JH et al. (2008a) Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli. Mol Imaging Biol 10: 54\u00e2\u0080\u009361.","DOI":"10.1007\/s11307-007-0120-5"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB43","doi-asserted-by":"crossref","unstructured":"Min JJ , Nguyen VH , Kim HJ , Hong Y & Choy HE (2008b) Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals. Nat Protoc 3: 629\u00e2\u0080\u0093636.","DOI":"10.1038\/nprot.2008.32"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB45","unstructured":"Osorio CG , Martinez-Wilson H & Camilli A (2004) The ompU paralogue vca1008 is required for virulence of Vibrio cholerae. J Bacteriol 186: 5167\u00e2\u0080\u00935171."},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB44","doi-asserted-by":"crossref","unstructured":"Osorio CG , Crawford JA , Michalski J , Martinez-Wilson H , Kaper JB & Camilli A (2005) Second-generation recombination-based in vivo expression technology for large-scale screening for Vibrio cholerae genes induced during infection of the mouse small intestine. Infect Immun 73: 972\u00e2\u0080\u0093980.","DOI":"10.1128\/IAI.73.2.972-980.2005"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB46","doi-asserted-by":"crossref","unstructured":"Rogers MB , Sexton JA , DeCastro GJ & Calderwood SB (2000) Identification of an operon required for ferrichrome iron utilization in Vibrio cholerae. J Bacteriol 182: 2350\u00e2\u0080\u00932353.","DOI":"10.1128\/JB.182.8.2350-2353.2000"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB47","doi-asserted-by":"crossref","unstructured":"Schild S , Tamayo R , Nelson EJ , Qadri F , Calderwood SB & Camilli A (2007) Genes induced late in infection increase fitness of Vibrio cholerae after release into the environment. Cell Host Microbe 2: 264\u00e2\u0080\u0093277.","DOI":"10.1016\/j.chom.2007.09.004"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB48","doi-asserted-by":"crossref","unstructured":"Silva AJ , Eko FO & Benitez JA (2008) Exploiting cholera vaccines as a versatile antigen delivery platform. Biotechnol Lett 30: 571\u00e2\u0080\u0093579.","DOI":"10.1007\/s10529-007-9594-0"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB49","doi-asserted-by":"crossref","unstructured":"Stokes MG , Titball RW , Neeson BN et al. (2007) Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis. Infect Immun 75: 1827\u00e2\u0080\u00931834.","DOI":"10.1128\/IAI.01242-06"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB57","first-page":"905","volume-title":"Vaccines","author":"Tacket","year":"2008"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB51","unstructured":"Tacket CO , Losonsky G , Nataro JP , Cryz SJ , Edelman R , Kaper JB & Levine MM (1992) Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J Infect Dis 166: 837\u00e2\u0080\u0093841."},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB50","doi-asserted-by":"crossref","unstructured":"Tacket CO , Cohen MB , Wasserman SS et al. (1999) Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba three months after vaccination. Infect Immun 67: 6341\u00e2\u0080\u00936345.","DOI":"10.1128\/IAI.67.12.6341-6345.1999"},{"key":"10.1111\/j.1574-695X.2009.00580.x-BIB53","doi-asserted-by":"crossref","unstructured":"Wiles S , Pickard KM , Peng K , MacDonald TT & Frankel G (2006) In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect Immun 74: 5391\u00e2\u0080\u00935396.","DOI":"10.1128\/IAI.00848-06"}],"container-title":["FEMS Immunology &amp; Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/57\/1\/69\/19171442\/57-1-69.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T23:52:21Z","timestamp":1710460341000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1111\/j.1574-695X.2009.00580.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1574-695x.2009.00580.x","relation":{},"ISSN":["0928-8244","1574-695X"],"issn-type":[{"value":"0928-8244","type":"print"},{"value":"1574-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}